Most Recent

Structuring Physician Leadership To Promote Accountable Care

Physician leadership is widely seen as crucial to drive accountable care and population health, but the question is how to structure such leadership.

April 17, 2015 | Organization and Delivery

From the Grantmakers in Health Annual Meeting: Patrick Kennedy on Behavioral Health

The opening plenary speaker was Patrick Kennedy, founder of The Kennedy Forum, which advocates for full implementation of the 2008 mental health parity law.

April 17, 2015 | GrantWatch, Insurance and Coverage

Workplace Wellness Programs: Federal Agencies Weigh In (Update on Contraceptive Coverage)

On April 16, 2015, several federal agencies released a barrage of regulatory issuances and guidances that further clarify their position on workplace wellness programs. Here's what they mean.

Reducing Inappropriate Psychotropic Prescribing For Children And Youth In Foster Care

There is currently a much-needed national spotlight on the high rates of psychotropic medication use among children and youth in foster care, most of whom receive health coverage through Medicaid.

Implementing Health Reform: Navigator Grants, Another ACA Challenge Rejected, And More

On April 15, 2015, the Centers for Medicare and Medicaid Service issued its funding opportunity announcement for 2016 navigator grants. On April 14, a federal appellate court dismissed another challenge to ACA implementation.

Interview: Dr. Gail Christopher, Vice President For Policy And Senior Advisor For The W.K. Kellogg Foundation

Shortly before Dr. Gail Christopher, vice president for policy and senior advisor for the W.K. Kellogg Foundation, received the Terrance Keenan Leadership Award in Health Philanthropy from Grantmakers in Health, I sat down with her to talk.

April 16, 2015 | Once in a Weil

From The WHO: Preventing The Next Ebola

As the senior leaders of the World Health Organization, we are taking action to prevent another emergency on the scale of the current Ebola outbreak from happening again.

New Cures Require New Pricing Policies

One critical incentive for ongoing drug discovery and development is the temporary monopoly pricing that manufacturers can command for novel drugs. Yet this incentive, embedded in current patent and regulatory policy, does not guarantee that manufacturers will deliver novel products with...

April 16, 2015 | Health Policy Lab

Refocusing Philanthropy after ACA Implementation

For the past several years, many of us in health philanthropy have seen the implementation of the Affordable Care Act (ACA) as a key opportunity for attention and investment. At the New York State Health Foundation (NYSHealth), we focused resources first on supporting and sharing policy...

The Payment Reform Landscape: Impact On Consumers

As we focus on reforming how we pay for health care, it is vital that we address key questions involving the very consumers who receive that care.